138 related articles for article (PubMed ID: 29689369)
1. Investigating elastic relaxation effects on the optical properties of functionalised calcium carbonate compacts using optics-based Heckel analysis.
Bawuah P; Karttunen AP; Markl D; Ridgway C; Korhonen O; Gane P; Zeitler JA; Ketolainen J; Peiponen KE
Int J Pharm; 2018 Jun; 544(1):278-284. PubMed ID: 29689369
[TBL] [Abstract][Full Text] [Related]
2. Compaction of functionalized calcium carbonate, a porous and crystalline microparticulate material with a lamellar surface.
Stirnimann T; Atria S; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
Int J Pharm; 2014 May; 466(1-2):266-75. PubMed ID: 24631309
[TBL] [Abstract][Full Text] [Related]
3. Optics-based compressibility parameter for pharmaceutical tablets obtained with the aid of the terahertz refractive index.
Chakraborty M; Ridgway C; Bawuah P; Markl D; Gane PAC; Ketolainen J; Zeitler JA; Peiponen KE
Int J Pharm; 2017 Jun; 525(1):85-91. PubMed ID: 28377315
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Pore Structure of Functionalized Calcium Carbonate Tablets by Terahertz Time-Domain Spectroscopy and X-Ray Computed Microtomography.
Markl D; Wang P; Ridgway C; Karttunen AP; Chakraborty M; Bawuah P; Pääkkönen P; Gane P; Ketolainen J; Peiponen KE; Zeitler JA
J Pharm Sci; 2017 Jun; 106(6):1586-1595. PubMed ID: 28267446
[TBL] [Abstract][Full Text] [Related]
5. On the role of API in determining porosity, pore structure and bulk modulus of the skeletal material in pharmaceutical tablets formed with MCC as sole excipient.
Ridgway C; Bawuah P; Markl D; Zeitler JA; Ketolainen J; Peiponen KE; Gane P
Int J Pharm; 2017 Jun; 526(1-2):321-331. PubMed ID: 28432018
[TBL] [Abstract][Full Text] [Related]
6. Detection of porosity of pharmaceutical compacts by terahertz radiation transmission and light reflection measurement techniques.
Bawuah P; Pierotic Mendia A; Silfsten P; Pääkkönen P; Ervasti T; Ketolainen J; Zeitler JA; Peiponen KE
Int J Pharm; 2014 Apr; 465(1-2):70-6. PubMed ID: 24530384
[TBL] [Abstract][Full Text] [Related]
7. Negative porosity issue in the Heckel analysis: A possible solution.
Patel D; Patel VD; Sedlock R; Haware RV
Int J Pharm; 2022 Nov; 627():122205. PubMed ID: 36122616
[TBL] [Abstract][Full Text] [Related]
8. Fast and non-destructive pore structure analysis using terahertz time-domain spectroscopy.
Markl D; Bawuah P; Ridgway C; van den Ban S; Goodwin DJ; Ketolainen J; Gane P; Peiponen KE; Zeitler JA
Int J Pharm; 2018 Feb; 537(1-2):102-110. PubMed ID: 29247699
[TBL] [Abstract][Full Text] [Related]
9. Non-contact weight measurement of flat-faced pharmaceutical tablets using terahertz transmission pulse delay measurements.
Bawuah P; Silfsten P; Ervasti T; Ketolainen J; Zeitler JA; Peiponen KE
Int J Pharm; 2014 Dec; 476(1-2):16-22. PubMed ID: 25245546
[TBL] [Abstract][Full Text] [Related]
10. Pressure susceptibility of polymer tablets as a critical property: a modified Heckel equation.
Kuentz M; Leuenberger H
J Pharm Sci; 1999 Feb; 88(2):174-9. PubMed ID: 9950634
[TBL] [Abstract][Full Text] [Related]
11. Influence of elastic deformation of particles on Heckel analysis.
Sun C; Grant DJ
Pharm Dev Technol; 2001; 6(2):193-200. PubMed ID: 11416993
[TBL] [Abstract][Full Text] [Related]
12. Terahertz study on porosity and mass fraction of active pharmaceutical ingredient of pharmaceutical tablets.
Bawuah P; Tan N; Tweneboah SN; Ervasti T; Axel Zeitler J; Ketolainen J; Peiponen KE
Eur J Pharm Biopharm; 2016 Aug; 105():122-33. PubMed ID: 27288937
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous investigation of the liquid transport and swelling performance during tablet disintegration.
Al-Sharabi M; Markl D; Mudley T; Bawuah P; Karttunen AP; Ridgway C; Gane P; Ketolainen J; Peiponen KE; Rades T; Zeitler JA
Int J Pharm; 2020 Jun; 584():119380. PubMed ID: 32407939
[TBL] [Abstract][Full Text] [Related]
14. Terahertz frequency domain sensing for fast porosity measurement of pharmaceutical tablets.
Moradikouchi A; Sparén A; Folestad S; Stake J; Rodilla H
Int J Pharm; 2022 Apr; 618():121579. PubMed ID: 35181461
[TBL] [Abstract][Full Text] [Related]
15. Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets.
Stirnimann T; Di Maiuta N; Gerard DE; Alles R; Huwyler J; Puchkov M
Pharm Res; 2013 Jul; 30(7):1915-25. PubMed ID: 23604923
[TBL] [Abstract][Full Text] [Related]
16. Early detection of capping risk in pharmaceutical compacts.
Xu X; Vallabh CKP; Hoag SW; Dave VS; Cetinkaya C
Int J Pharm; 2018 Dec; 553(1-2):338-348. PubMed ID: 30367987
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Young's modulus of pharmaceutical tablet obtained by terahertz time-delay measurement.
Peiponen KE; Bawuah P; Chakraborty M; Juuti M; Zeitler JA; Ketolainen J
Int J Pharm; 2015 Jul; 489(1-2):100-5. PubMed ID: 25934425
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive porosity measurement of biconvex tablets using terahertz pulses.
Bawuah P; Ervasti T; Tan N; Zeitler JA; Ketolainen J; Peiponen KE
Int J Pharm; 2016 Jul; 509(1-2):439-443. PubMed ID: 27289013
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets.
Wagner-Hattler L; Wyss K; Schoelkopf J; Huwyler J; Puchkov M
Int J Pharm; 2017 Dec; 534(1-2):50-59. PubMed ID: 28987455
[TBL] [Abstract][Full Text] [Related]
20. Impact of functionalized particle structure on roll compaction/dry granulation and tableting of calcium carbonate.
Grote S; Kleinebudde P
Int J Pharm; 2018 Jun; 544(1):235-241. PubMed ID: 29689365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
